Effects of anticancer agents on cell viability, proliferative activity and cytokine production of peripheral blood mononuclear cells
Open Access
- 1 January 2013
- journal article
- Published by The Society for Free Radical Research Japan in Journal of Clinical Biochemistry and Nutrition
- Vol. 52 (1) , 64-71
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 25 references indexed in Scilit:
- A Combination Therapy of Gemcitabine With Immunotherapy for Patients With Inoperable Locally Advanced Pancreatic CancerPancreas, 2009
- Combined effects of 5-Fluorouracil, Folinic acid and Oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapyJournal of Experimental & Clinical Cancer Research, 2008
- Immunological aspects of cancer chemotherapyNature Reviews Immunology, 2008
- Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experienceInvestigational New Drugs, 2006
- Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cellsJournal of Clinical Investigation, 2005
- Regulatory T Cells in Ovarian Cancer: Biology and Therapeutic PotentialAmerican Journal of Reproductive Immunology, 2005
- Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune ActivityClinical Cancer Research, 2005
- Restored immune response to an MHC-II-Restricted antigen in tumor-bearing hosts after elimination of regulatory T cellsJournal of Pediatric Surgery, 2004
- In vitro studies on the immunosuppressive effect of 2′,2′-difluorodeoxycytidine (dFdC) and its metabolite 2′,2′-difluorodeoxyuridine (dFdU)Immunobiology, 2003
- Mechanism of Synergy of Levamisole and Fluorouracil: Induction of Human Leukocyte Antigen Class I in a Colorectal Cancer Cell LineJNCI: Journal of the National Cancer Institute, 1995